Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8501703 Chimeric oligomeric compounds for modulation of splicing

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 29, 2006
Date of Patent
August 6, 2013
Patent Application Number
12065250
Patent Citations Received
‌
US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease
0
‌
US Patent 12064483 Nucleic acid-polypeptide compositions and methods of inducing exon skipping
0
‌
US Patent 12071621 Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
0
‌
US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 11834661 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
‌
US Patent 11872287 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 11873490 Antisense oligomers for treatment of conditions and diseases
0
‌
US Patent 11879125 GalNAc compositions for improving siRNA bioavailability
0
‌
US Patent 11891605 Reducing intron retention
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8501703
Patent Primary Examiner
‌
Kimberly Chong

Find more entities like US Patent 8501703 Chimeric oligomeric compounds for modulation of splicing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.